Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy

Neurology

Volumn 73, Issue 7, 2009, Pages 511-517

  Honda, M ^a,b   Arai, T ^a   Fukazawa, M ^a   Honda, Y ^b   Tsuchiya, K ^c   Salehi, A ^c   Akiyama, H ^a   Mignot, E ^c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; OREXIN; TAR DNA BINDING PROTEIN; TAU PROTEIN; UBIQUITIN;

AGED; ARTICLE; CASE REPORT; CATAPLEXY; CELL INCLUSION; CELL LOSS; COMORBIDITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMENTIA; FEMALE; GLIOSIS; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NARCOLEPSY; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; UBIQUITINATION;

EID: 69449097348     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181b2a6af     Document Type: Article

References (23)

1. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997.
2. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-474. (Pubitemid 30951849)
3. van den Pol AN. Narcolepsy: a neurodegenerative disease of the hypocretin system? Neuron 2000;27:415-418.
4. Scammell TE. The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy. Sleep 2006;29:601-602.
5. Gray DA, Tsirigotis M, Woulfe J. Ubiquitin, proteasomes, and the aging brain. Sci Aging Knowledge Environ 2003;2003:RE6.
6. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133. (Pubitemid 44547757)
7. Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602-611. (Pubitemid 44708852)
8. Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 2007;130:1577-1585. (Pubitemid 47355929)
9. Thannickal TC, Lai YY, Siegel JM. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007;130:1586-1595. (Pubitemid 47355933)
10. Benarroch EE, Schmeichel AM, Sandroni P, Low PA, Parisi JE. Involvement of hypocretin neurons in multiple system atrophy. Acta Neuropathol 2007;113:75-80. (Pubitemid 44782931)
11. Petersen A, Gil J, Maat-Schieman ML, et al. Orexin loss in Huntington's disease. Hum Mol Genet 2005;14:39-47.
12. Love S, Bridges LR, Case CP. Neurofibrillary tangles in Niemann-Pick disease type C. Brain 1995;118(pt 1):119-129.
13. Crocker A, Espana RA, Papadopoulou M, et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 2005;65:1184-1188.
14. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486. (Pubitemid 19239715)
15. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
16. Mai JK, Assheuer J, Paxinos G. Atlas of the Human Brain. San Diego: Academic Press; 1997.
17. Hasegawa M, Jakes R, Crowther RA, Lee VM, Ihara Y, Goedert M. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett 1996;384:25-30. (Pubitemid 26111925)
18. Obi K, Akiyama H, Kondo H, et al. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Exp Neurol 2008;210:409-420.
19. Kametani F, Tanaka K, Ishii T, Ikeda S, Kennedy HE, Allsop D. Secretory form of Alzheimer amyloid precursor protein 695 in human brain lacks beta/A4 amyloid immunoreactivity. Biochem Biophys Res Commun 1993;191:392-398. (Pubitemid 23222648)
20. Hasegawa M, Arai T, Nonaka T, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 2008;64:60-70.
21. Saper CB, German DC. Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 1987;74:364-370.
22. Yamada M, Itoh Y, Otomo E, Suematsu N, Masushita M. Dementia of the Alzheimer type and related dementias in the aged: DAT subgroups and senile dementia of the neurofibrillary tangle type. Neuropathology 1996;16:89-98. (Pubitemid 26192875)
23. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004;10(suppl):S10-S17.